MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
2 clinical trials · Condition
◉ Watch MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
| Record | Firm | Date |
|---|---|---|
| Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC (NCT07003022) | Fudan University | 2025-06-01 |
| Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. (NCT05838768) | Novartis Pharmaceuticals | 2023-06-27 |
Track MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers automatically
Every clearance here is in the API, with alerts when new ones post.